BR0004813A - Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori - Google Patents

Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori

Info

Publication number
BR0004813A
BR0004813A BR0004813-5A BR0004813A BR0004813A BR 0004813 A BR0004813 A BR 0004813A BR 0004813 A BR0004813 A BR 0004813A BR 0004813 A BR0004813 A BR 0004813A
Authority
BR
Brazil
Prior art keywords
pylori
infections
cytoprotection
treatment
vesicular
Prior art date
Application number
BR0004813-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of BR0004813A publication Critical patent/BR0004813A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0004813-5A 1999-01-25 2000-01-24 Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori BR0004813A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN141DE1999 IN190017B (cg-RX-API-DMAC10.html) 1999-01-25 1999-01-25
PCT/IN2000/000004 WO2000042987A2 (en) 1999-01-25 2000-01-24 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections

Publications (1)

Publication Number Publication Date
BR0004813A true BR0004813A (pt) 2000-11-21

Family

ID=11088428

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0004813-5A BR0004813A (pt) 1999-01-25 2000-01-24 Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori

Country Status (8)

Country Link
US (1) US6306838B1 (cg-RX-API-DMAC10.html)
EP (1) EP1105097A2 (cg-RX-API-DMAC10.html)
JP (1) JP2002535266A (cg-RX-API-DMAC10.html)
AU (1) AU3322100A (cg-RX-API-DMAC10.html)
BR (1) BR0004813A (cg-RX-API-DMAC10.html)
IN (1) IN190017B (cg-RX-API-DMAC10.html)
RU (1) RU2207113C2 (cg-RX-API-DMAC10.html)
WO (1) WO2000042987A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE432691T1 (de) * 2000-03-28 2009-06-15 Sandoz Ag Geschmackmaskierte granulierte teilchen
US6576625B2 (en) * 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
EP1350507A1 (en) * 2002-04-04 2003-10-08 Applied NanoSystems B.V. Delivery of a substance to a pre-determinated site
JP4926707B2 (ja) 2003-08-22 2012-05-09 ダニスコ エイ／エス 封入化抗菌材料
RU2378830C2 (ru) * 2003-08-22 2010-01-20 Даниско А/С Инкапсулированный антимикробный материал
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads
WO2006015423A1 (en) * 2004-08-11 2006-02-16 Clifford C Holloway Method and apparatus for collection and treatment of encapsulated waste
RU2320323C1 (ru) * 2006-08-03 2008-03-27 Игорь Александрович Базиков Система доставки биологически активных веществ с помощью ниосом
US20180177725A1 (en) * 2015-09-10 2018-06-28 Washington State University Cell membrane-formed nanoscale vesicles and methods of using thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
AU652778B2 (en) * 1990-10-15 1994-09-08 Quest International B.V. Treatment composition
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
EP0676199B1 (en) 1994-04-07 1998-09-02 Pfizer Inc. Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections
GB9407869D0 (en) 1994-04-20 1994-06-15 Caduceus Ltd Antimicrobial compounds
FR2718965B1 (fr) 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle application thérapeutique de la spiramycine.
AU6580494A (en) 1994-05-11 1995-12-05 P.N. Gerolymatos S.A. Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
GB9505032D0 (en) * 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
AU4596796A (en) 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
WO1996024368A1 (en) * 1995-02-07 1996-08-15 Lectin Biopharma, Inc. Method of using lectins for prevention and treatment of oral and alimentary tract disorders

Also Published As

Publication number Publication date
RU2207113C2 (ru) 2003-06-27
JP2002535266A (ja) 2002-10-22
US6306838B1 (en) 2001-10-23
WO2000042987A2 (en) 2000-07-27
EP1105097A2 (en) 2001-06-13
WO2000042987A3 (en) 2000-11-02
WO2000042987A8 (en) 2001-06-28
AU3322100A (en) 2000-08-07
IN190017B (cg-RX-API-DMAC10.html) 2003-05-31

Similar Documents

Publication Publication Date Title
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
CY1115916T1 (el) Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου
BR9914044A (pt) ésteres tetrahidropirido
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
UY26130A1 (es) Compuestos para tratar la obesidad
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9808812A (pt) Composição compreendendo partìculas cristalinas, finamente divididas de budesonida
BR9810312A (pt) Composição farmacêutica que apresenta atividade antitumoral acentuada e/ou efeitos colaterais reduzidos contendo um agente antitumoral e um derivado do ácido hidroxìmico
PT998287E (pt) Utilizacao de levobupivacaina
BRPI0411295A (pt) compostos e seu uso na terapia
BR0211450A (pt) Método terapêutico
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
BR0312845A (pt) Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas
PA8452701A1 (es) Agonistas de prostaglandinas
BR9808140A (pt) Formulação unitária
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
ES2098207T1 (es) Producto para el cuidado de la piel y procedimiento de utilizacion.
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4 A 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.